Email this article Adoptive immunotherapy with interleukin-2 and lymphokine-activated killers in patients with malignant neoplasms of the female reproductive system (a review of literature)
- Authors: Gritsai A.N.1, Baranovsky D.A.2, Kiselevsky M.V.1, Gulyaeva I.L.3
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center, Moscow
- Department of Oncology, A. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
- Department of Pathological Physiology, E.A.Vagner Perm State Medical University Ministry of Health of Russia
- Issue: No 4 (2014)
- Pages: 71-73
- Section: GYNECOLOGY. TREATMENT
- Published: 06.11.2014
- URL: https://ojrs.abvpress.ru/ojrs/article/view/413
- DOI: https://doi.org/10.17650/1994-4098-2014-0-4-71-73
- ID: 413
Cite item
Full Text
Abstract
The review highlights current approaches to adoptive immunotherapy in patients with malignant neoplasms of the female reproductive system.
In spite of the obvious advances made by scientists of the world in treating malignant neoplasms, the existing treatment options remain insufficiently effective. To search for novel highly effective and safe treatments is an urgent problem of oncology. Adoptive immunotherapy is one of the priorities in this regard.
About the authors
A. N. Gritsai
N.N. Blokhin Russian Cancer Research Center, MoscowRussian Federation
D. A. Baranovsky
Department of Oncology, A. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
Author for correspondence.
Email: baranovski.duma@yandex.ru
Russian Federation
M. V. Kiselevsky
N.N. Blokhin Russian Cancer Research Center, MoscowRussian Federation
I. L. Gulyaeva
Department of Pathological Physiology, E.A.Vagner Perm State Medical University Ministry of Health of RussiaRussian Federation
References
Supplementary files
